Measuring response in solid tumors: comparison of RECIST and WHO response criteria. - Wikidata - wikimedia - TriplyDB

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

http://www.wikidata.org/entity/Q47378801

about

Ganoderma lucidum(Reishi mushroom) for cancer treatment Platinum versus non-platinum chemotherapy regimens for small cell lung cancer Ganoderma lucidum(Reishi mushroom) for cancer treatment Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysis Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature Brain imaging in drug R&D.Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma Kanglaite injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients: A systematic review and meta-analysis.Attenuated effects of Jianpi Qushi herbs on patients receiving FOLFOX4 after colorectal cancer surgery: A meta-analysis.Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study Response Evaluation of Chemotherapy for Lung Cancer.Commercial laboratory testing of excision repair cross-complementation group 1 expression in non-small cell lung cancer Preclinical multimodality phantom design for quality assurance of tumor size measurement Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review The effects of applying breast compression in dynamic contrast material-enhanced MR imaging Platinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis.The effectiveness of RECIST on survival in patients with NSCLC receiving chemotherapy with or without target agents as first-line treatment.Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.Treatment of in-transit melanoma with intra-lesional interleukin-2: a systematic review.Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy.Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.Drug development in oncology: classical cytotoxics and molecularly targeted agents.Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma Molecular Magnetic Resonance Imaging of Tumor Response to Therapy.The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer A Low-Cost Fiducial Reference Phantom for Computed Tomography Evaluation of a cloud-based local-read paradigm for imaging evaluations in oncology clinical trials for lung cancer A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.Correlation between histological grade and positron emission tomography parameters in cervical carcinoma.Efficacy of minimally invasive therapies on unresectable pancreatic cancer.Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma.Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab.

P2860

Q24185921-89B4E174-F383-4007-A5E8-49D991140082 Q24188039-BCB093C3-231B-413C-8F9F-A76A91E281EF Q24202814-4F3E1B00-9008-4CC1-BC13-0865503B920A Q26772329-E5327DC9-A23D-4BDA-89D3-0B083B566092 Q28072200-965D7AD5-F1ED-4A7D-BEB5-D57C34E6BAEF Q28475128-D32369AF-4FC0-4F82-AB63-755B8239FE85 Q31019812-2760EE04-9F42-4BE9-9477-C377B16870F8 Q33382596-F52A67B2-E252-40EB-974A-AD81871692EA Q33414373-D3A9F64B-3036-40D5-B0A7-B241390A140F Q33429295-D25EE5AC-F094-40B4-8BEB-A52649C0040C Q33506194-90E1E467-D1C4-4D09-8B6A-7B03C64368C6 Q33567345-C0A60621-0F42-4665-9744-57FAEC1BF192 Q33577811-E6D20476-B8E7-4AA6-B866-25146F360FB0 Q34035194-EC9014CA-97F7-454F-B9D9-C74F85C4F750 Q34433737-A71FF7C8-6E24-4B2C-8A97-F44BB511EA16 Q34550662-65D01874-1DAC-4147-AEEA-9D4D1AC39C99 Q34566213-A4E9770E-1C7B-4A97-8377-DDD79604EE2B Q34681250-0FC8744D-00FC-4324-BA6F-F86DEF5166D2 Q34852173-62685707-90BB-4AAE-B234-21DACEA6011A Q34865296-761552C9-4B33-4549-8C94-74AE68F66C66 Q34982068-47E8DBA6-F18C-4BCA-AF8D-0A4FD990D2C4 Q35051942-A0262062-CC05-4EB2-9877-5DF6758B78E6 Q35142268-B56D8342-83A1-4FEA-9C9B-3ABA2A87DC6C Q35201353-F918886D-6B0E-4693-BDAB-C92EF5402F92 Q35739540-0B6AF32D-4163-4DBD-9837-61D9E16BF2E7 Q35800552-DE4F4037-A253-4A86-918D-734A361E8AF3 Q35800569-35AE0B58-19A3-4AD3-AB0E-22BE31E64408 Q35827606-23F325BC-55D2-4EBF-B519-754FA3357627 Q35840022-B1D871FB-C054-497A-B6A8-48DE4D4CEF2A Q36009402-AF7EEB7E-8D3C-4BAA-BA27-02ABE07A986F Q36123378-4DFE43F3-C735-48FB-AA73-80AFBCC75290 Q36134671-5E1ECB05-F611-45DE-BF87-28F31B66334A Q36299395-DD566E55-B40E-47F6-9CE3-F61EB84BEBE3 Q36345062-EAC20692-BF4E-4CA4-8B46-625797D8F7E7 Q36696431-6143AFF7-076E-4D60-81DC-3702D1533D6F Q37076617-229DB090-850A-467E-9E85-7BEBDA37365A Q37106866-865C46CD-57CB-4DF2-9BE6-240434D5BD75 Q37354138-C6F5CFF1-1C9A-4726-B886-B4470E8C9E43 Q37449210-BAD8CFDD-4EAD-44EA-AAF7-4F205C983BA4 Q37450606-617B4404-06B5-44B9-B035-6FB6537E1255

P2860

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

http://www.wikidata.org/entity/Q47378801

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@en

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@nl

type

label

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@en

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@nl

prefLabel

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@en

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@nl

P1433

Q47378801-7008B869-507C-45F1-8AA2-39FED6D04C0B

P1476

Q47378801-1C3FF918-56DA-4317-9A14-1451741240D0

P2093

Q47378801-35A4E109-E38B-44B0-8DF4-AE3C2C9EC011

Q47378801-4C95E51F-20DF-4023-8C85-6DBDEADAFD5E

Q47378801-6A643524-1740-42F2-A7AB-70BEE938E5E4

Q47378801-853F4280-F39B-4664-9976-8A573DD20EC6

Q47378801-99C4BD28-D51B-43B9-AB7B-387F99C8CE8E

Q47378801-9BBAA19C-C329-493A-ACA0-0B08B9E4C08A

Q47378801-9C150C55-B9D9-4392-A764-3F13C450ED24

Q47378801-A5A64BE7-F2FC-47CE-85DC-DBCBE71AB913

Q47378801-A7673804-1D40-47DA-9350-B99590080A67

Q47378801-C4434C81-1ECA-4465-8D10-A40B18348242

P304

Q47378801-33E31B03-74DE-44E9-A83C-51E9D8CF5637

P31

Q47378801-17C3B879-6E52-435E-9FD7-6E30744E5393

P356

Q47378801-804BD62B-E90E-4DD1-A4CD-0F1D0FADFB97

P433

Q47378801-DCE0F51E-9474-478C-A7F5-0A92D61BF5B3

P478

Q47378801-564B281E-0EAA-41A8-B35A-37A0FC799153

P577

Q47378801-45B8272F-0740-44BA-911B-2BB280BC3A56

P698

Q47378801-849E7B60-75A1-4482-800D-F56F92D5D1D0

P356

P1433

Japanese Journal of Clinical Oncology

P1476

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

@en

P2093

Chul Won Jung

http://www.w3.org/2001/XMLSchema#string

Joon Oh Park

http://www.w3.org/2001/XMLSchema#string

Keunchil Park

http://www.w3.org/2001/XMLSchema#string

Kihyun Kim

http://www.w3.org/2001/XMLSchema#string

Kyung Soo Lee

http://www.w3.org/2001/XMLSchema#string

Mark Hong Lee

http://www.w3.org/2001/XMLSchema#string

Seo Young Song

http://www.w3.org/2001/XMLSchema#string

Soon Il Lee

http://www.w3.org/2001/XMLSchema#string

Won Ki Kang

http://www.w3.org/2001/XMLSchema#string

Won Seog Kim

http://www.w3.org/2001/XMLSchema#string

P304

533-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYG093

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14623923

http://www.w3.org/2001/XMLSchema#string